Scientific medical educational event on the management of premenopausal breast cancer patients. Aim is to raise awareness and share practical topics on the specific management of these patients by medical experts in this field. The meeting and topics are non-branded, but this is a patient population that is often neglected as well in clinical trials.
Scientific medical educational event on the management of premenopausal breast cancer patients. Aim is to raise awareness and share practical topics on the specific management of these patients by medical experts in this field. Speakers will give a 15 minutes lecture on each topic followed by a Q&A and panel discussion.
The activity will be split in two parts: - Part 1: targets physicians as some topics are related to treatment of premenopausal breast cancer - Part 2: targets physicians and nurses as the topics are related to the management of these patients.
The national speakers will present their topics through from the vendor’s studio, the international speakers remotely. There will be a Q&A and panel discussion with external moderator at the end of each session. The questions will be screened for off-label content by Novartis. ln the current COVID-19 situation, the symposium will be virtual. It is not adjacent to another meeting. Expected max 100 HCP’s are expected to attend for Belgium The Dutch Novartis colleagues can also invite their physicians with an expected max of 50 physicians.
Novartis Oncology maakt deel uit van het Novartis Pharma bedrijf.Onze missie is het verlengen en verbeteren van de levens van patiënten met kanker door het mede ontwikkelen en succesvol op de markt brengen van innovatieve geneesmiddelen.